Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus plus reduced-dose tacrolimus versus mycophenolate sodium plus reduced-dose tacrolimus after liver transplantation
RBR-9k66x6Recruiting
- Sponsor
- Hospital Geral de Fortaleza
- Start
- Jan 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of everolimus, mycophenolate sodium and tacrolimus in liver transplant (2 arms), sponsored by Hospital Geral de Fortaleza. Started Jan 2016; status: recruiting.
02
Drugs
everolimusmycophenolate sodiumtacrolimus
03
Conditions
liver transplant
Beyond the preview
Go deeper on RBR-9k66x6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9k66x6.